Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Eugene Jerome Mark, M.D.

Co-Author

This page shows the publications co-authored by Eugene Mark and Michael Lanuti.
Connection Strength

0.273
  1. Reply to Wijmans et al.: Optical Coherence Tomography: A Valuable Novel Tool for Assessing the Alveolar Compartment in Interstitial Lung Disease? Am J Respir Crit Care Med. 2018 05 01; 197(9):1232-1233.
    View in: PubMed
    Score: 0.046
  2. Endobronchial Optical Coherence Tomography for Low-Risk Microscopic Assessment and Diagnosis of Idiopathic Pulmonary Fibrosis In Vivo. Am J Respir Crit Care Med. 2018 04 01; 197(7):949-952.
    View in: PubMed
    Score: 0.046
  3. Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases. J Thorac Oncol. 2017 03; 12(3):458-466.
    View in: PubMed
    Score: 0.042
  4. Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment. J Thorac Oncol. 2016 11; 11(11):1869-1878.
    View in: PubMed
    Score: 0.041
  5. Diagnosing lung carcinomas with optical coherence tomography. Ann Am Thorac Soc. 2015 Feb; 12(2):193-201.
    View in: PubMed
    Score: 0.037
  6. Toward the guidance of transbronchial biopsy: identifying pulmonary nodules with optical coherence tomography. Chest. 2013 Oct; 144(4):1261-1268.
    View in: PubMed
    Score: 0.034
  7. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011 Mar 23; 3(75):75ra26.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.